Given that SPX has recently been identified as a significant regulator of metabolic and reproductive functions and considering the higher risk of NAFLD among women with PCOS, this study seeks to investigate whether SPX could serve as a potential biomarker for assessing the severity of liver steatosis in this population. This evidence concerns the gene SPX and metabolic dysfunction-associated steatotic liver disease.